News report 📈 Stocks 🌍 United States

Jaguar Health to Execute 1-for-25 Reverse Stock Split on November 24, 2026

Jaguar Health, Inc. (JAGX) will implement a 1-for-25 reverse stock split on November 24, 2026, accompanied by a CUSIP change to 47010C839.

🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 1 Bearish, 0 Neutral. Strongest signal: JAGX ↓ 4/10 (60% confidence).

📊 Affected Assets (1)

JAGX
Bearish 🤖 60%
📅 Short-term 🌍 US · Explicit

Jaguar Health will execute a one-for-twenty-five reverse stock split effective November 24, 2026, with the CUSIP changing to 47010C839. While the split itself is value-neutral, a split this large signals the shares trade at a distressed level and can trigger selling pressure as investors anticipate continued weakness. Trading and liquidity may also be disrupted around the effective date.

Catalysts
  • ▼ 1-for-25 reverse stock split effective Tuesday, November 24, 2026
  • ▼ CUSIP number change to 47010C839 in conjunction with the split
Risk Factors
  • ▲ Reverse split is mechanically value-neutral and requires no change in valuation
  • ▲ Market maker registration is open, which could support liquidity after the split

🎯 Key Takeaways

  • Jaguar Health will execute a 1-for-25 reverse stock split effective November 24, 2026.
  • The company's CUSIP number will change to 47010C839 following the reverse split.
  • Nasdaq is currently accepting market maker registrations for JAGX shares.

📝 Executive Summary

Jaguar Health, Inc. (JAGX) has announced a 1-for-25 reverse stock split of its common stock, effective Tuesday, November 24, 2026. In connection with this corporate action, the company's CUSIP number will be updated to 47010C839.

❓ FAQ

Will I lose money when Jaguar Health does the reverse split?

The 1-for-25 reverse split is value-neutral: every 25 shares become 1 share and the share price is adjusted proportionately, so the split itself does not change the value of a holding.

Why is Jaguar Health doing a reverse split?

The article only states that the company will effect a one-for-twenty-five reverse split of its Common Stock effective November 24, 2026, along with a CUSIP change to 47010C839; it does not give a reason.